Can CereVasc’s $85m raise move hydrocephalus treatment beyond traditional shunt surgery?
CereVasc’s $85m raise backs eShunt, a minimally invasive hydrocephalus device. The STRIDE trial now carries the real test.
Medical Devices & Diagnostics
Medical Devices & Diagnostics
Can ZETA SURGICAL turn brain biopsy and hydrocephalus procedures into point-of-care care?
Neurosurgery needs precision beyond elite hospitals. ZETA SURGICAL’s FDA clearance puts AI-guided access to the real-world test.